Wells Fargo’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $163K | Buy |
38,215
+14,976
| +64% | +$63.8K | ﹤0.01% | 4498 |
|
|
2025
Q1 | $87.4K | Buy |
23,239
+514
| +2% | +$1.93K | ﹤0.01% | 4724 |
|
|
2024
Q4 | $132K | Buy |
22,725
+5,958
| +36% | +$34.7K | ﹤0.01% | 4555 |
|
|
2024
Q3 | $200K | Buy |
16,767
+457
| +3% | +$5.46K | ﹤0.01% | 4197 |
|
|
2024
Q2 | $176K | Buy |
16,310
+6,630
| +68% | +$71.7K | ﹤0.01% | 4242 |
|
|
2024
Q1 | $110K | Buy |
9,680
+1,222
| +14% | +$13.8K | ﹤0.01% | 4469 |
|
|
2023
Q4 | $119K | Buy |
8,458
+1,733
| +26% | +$24.3K | ﹤0.01% | 4394 |
|
|
2023
Q3 | $83.1K | Sell |
6,725
-3,568
| -35% | -$44.1K | ﹤0.01% | 4557 |
|
|
2023
Q2 | $92.9K | Buy |
10,293
+10,047
| +4,084% | +$90.7K | ﹤0.01% | 4823 |
|
|
2023
Q1 | $854 | Buy |
246
+4
| +2% | +$14 | ﹤0.01% | 6103 |
|
|
2022
Q4 | $593 | Buy |
242
+6
| +3% | +$15 | ﹤0.01% | 6016 |
|
|
2022
Q3 | $1K | Buy |
236
+36
| +18% | +$153 | ﹤0.01% | 6083 |
|
|
2022
Q2 | $1K | Sell |
200
-1,588
| -89% | -$7.94K | ﹤0.01% | 6263 |
|
|
2022
Q1 | $8K | Sell |
1,788
-8,833
| -83% | -$39.5K | ﹤0.01% | 5993 |
|
|
2021
Q4 | $99K | Buy |
10,621
+9,866
| +1,307% | +$92K | ﹤0.01% | 5240 |
|
|
2021
Q3 | $21K | Buy |
+755
| New | +$21K | ﹤0.01% | 5643 |
|
|
2021
Q2 | – | Sell |
-3,839
| Closed | -$128K | – | 6878 |
|
|
2021
Q1 | $128K | Buy |
3,839
+3,809
| +12,697% | +$127K | ﹤0.01% | 5045 |
|
|
2020
Q4 | $1K | Buy |
+30
| New | +$1K | ﹤0.01% | 6022 |
|